Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Jubbonti (denosumab-bddz)
i
Other names:
GP2411, GP-2411
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Sandoz
Drug class:
RANK ligand inhibitor
Related drugs:
‹
denosumab (13)
LY01011 (denosumab biosimilar) (0)
denosumab (13)
LY01011 (denosumab biosimilar) (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
denosumab-bddz
Sensitive: A1 - Approval
denosumab-bddz
Sensitive
:
A1
denosumab-bddz
Sensitive: A1 - Approval
denosumab-bddz
Sensitive
:
A1
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login